Loading…

Once-Daily Lixisenatide in Combination with Basal Insulin ± Oral Antihyperglycemic Agents in Patients with Type 2 Diabetes Selectively Reduces Postprandial Hyperglycemic Daytime Exposure

Saved in:
Bibliographic Details
Published in:Canadian journal of diabetes 2013-10, Vol.37, p.S31-S31
Main Authors: Bajaj, Harpreet S, Gomez-Huelgas, Ricardo, Riddle, Matthew C, Seino, Yutaka, Cariou, Bertrand, Roy-Duval, Christine, Hecquet, Carole A, Digenio, Andres, Rosenstock, Julio
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1499-2671
2352-3840
DOI:10.1016/j.jcjd.2013.08.090